Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
Retatrutide, which has not yet completed clinical trials, is an experimental injection developed by the US drugmaker Eli Lilly that targets three gut hormones: GLP-1, GIP and glucagon
While it's stable during transit, getting it into a controlled environment is the first priority
Li J, Zhang N, Hu L, et al
IGF-1, sleep quality, recovery, and body composition are tracked across each cycle
US$ 25.97
US$ 20.92
US$ 22.32
US$ 26.60
US$ 26.28
US$ 27.96
US$ 28.73
US$ 27.61
US$ 22.19
